Introduction COVID-19 is associated to an increased risk of thrombosis, as a result of a
complex process that involves the activation of vascular and circulating cells, the release of …

Platelets are key vascular effectors in hemostasis, with activation signals leading to fast
recruitment, aggregation, and clot formation. The canonical process of hemostasis is well …

Uncontrolled bleeding is the leading cause of death, and the death risk of bleeding from
coagulopathy is even higher. By infusing the relevant coagulation factors, bleeding in …

Background: During long-term antiplatelet agents (APAs) administration, patients with
thrombotic diseases take a fairly high risk of life-threatening bleeding, especially when in …

Hemostatic powders can be used for deep wounds and wounds with irregular shapes that
are frequently inaccessible to traditional hemostatic dressings like hemostatic gauze …

Traumatic haemorrhage is a prevalent clinical condition, and effective and timely
haemostasis is crucial for the preservation of patients' lives. In recent years, injectable …

Porous carbon spheres (PCS) with different specific surface areas and porous structures
were prepared by templated self-assembly method. The as-prepared PCS had uniform …

Inherited platelet disorders (IPDs) comprise a heterogeneous group of entities that manifest
with variable bleeding tendencies. For successful treatment, the underlying platelet disorder …

Trauma leading to severe hemorrhage and shock on average kills patients within 3 to 6
hours after injury. With average prehospital transport times reaching 1-6 hours in low-to …

Global public health is seriously threatened by thrombotic disorders because of their high
rates of mortality and disability. Most thrombolytic agents, especially protein-based …